Zymergen Inc
(ZY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | |
| Cash Flows From Operating Activities | |
| Net Income | -236,803 |
| Depreciation Amortization | 15,199 |
| Other Working Capital | 2,055 |
| Other Operating Activity | 23,991 |
| Operating Cash Flow | $-195,558 |
| Cash Flows From Investing Activities | |
| PPE Investments | -22,852 |
| Investing Cash Flow | $-22,852 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 37,601 |
| Financing Cash Flow | $37,601 |
| Beginning Cash Position | 343,851 |
| End Cash Position | 163,042 |
| Net Cash Flow | $-180,809 |
| Free Cash Flow | |
| Operating Cash Flow | -195,558 |
| Free Cash Flow | -195,558 |